Ras dimer formation as a new signaling mechanism and potential cancer therapeutic target

Mo Chen, Alec Peters, Tao Huang, Xiaolin Nan

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The K-, N-, and HRas small GTPases are key regulators of cell physiology and are frequently mutated in human cancers. Despite intensive research, previous efforts to target hyperactive Ras based on known mechanisms of Ras signaling have been met with little success. Several studies have provided compelling evidence for the existence and biological relevance of Ras dimers, establishing a new mechanism for regulating Ras activity in cells additionally to GTP-loading and membrane localization. Existing data also start to reveal how Ras proteins dimerize on the membrane. We propose a dimer model to describe Ras-mediated effector activation, which contrasts existing models of Ras signaling as a monomer or as a 5-8 membered multimer. We also discuss potential implications of this model in both basic and translational Ras biology.

Original languageEnglish (US)
Pages (from-to)391-403
Number of pages13
JournalMini-Reviews in Medicinal Chemistry
Volume16
Issue number5
StatePublished - Mar 1 2016

Fingerprint

ras Proteins
Cell Physiological Phenomena
Membranes
Monomeric GTP-Binding Proteins
Guanosine Triphosphate
Neoplasms
Therapeutics
Research

Keywords

  • Cancer
  • Membrane clustering
  • Ras dimer
  • Ras signaling
  • Targeted therapy

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Ras dimer formation as a new signaling mechanism and potential cancer therapeutic target. / Chen, Mo; Peters, Alec; Huang, Tao; Nan, Xiaolin.

In: Mini-Reviews in Medicinal Chemistry, Vol. 16, No. 5, 01.03.2016, p. 391-403.

Research output: Contribution to journalArticle

@article{273a4868e08b4b319c9ade3693a3b372,
title = "Ras dimer formation as a new signaling mechanism and potential cancer therapeutic target",
abstract = "The K-, N-, and HRas small GTPases are key regulators of cell physiology and are frequently mutated in human cancers. Despite intensive research, previous efforts to target hyperactive Ras based on known mechanisms of Ras signaling have been met with little success. Several studies have provided compelling evidence for the existence and biological relevance of Ras dimers, establishing a new mechanism for regulating Ras activity in cells additionally to GTP-loading and membrane localization. Existing data also start to reveal how Ras proteins dimerize on the membrane. We propose a dimer model to describe Ras-mediated effector activation, which contrasts existing models of Ras signaling as a monomer or as a 5-8 membered multimer. We also discuss potential implications of this model in both basic and translational Ras biology.",
keywords = "Cancer, Membrane clustering, Ras dimer, Ras signaling, Targeted therapy",
author = "Mo Chen and Alec Peters and Tao Huang and Xiaolin Nan",
year = "2016",
month = "3",
day = "1",
language = "English (US)",
volume = "16",
pages = "391--403",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Ras dimer formation as a new signaling mechanism and potential cancer therapeutic target

AU - Chen, Mo

AU - Peters, Alec

AU - Huang, Tao

AU - Nan, Xiaolin

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The K-, N-, and HRas small GTPases are key regulators of cell physiology and are frequently mutated in human cancers. Despite intensive research, previous efforts to target hyperactive Ras based on known mechanisms of Ras signaling have been met with little success. Several studies have provided compelling evidence for the existence and biological relevance of Ras dimers, establishing a new mechanism for regulating Ras activity in cells additionally to GTP-loading and membrane localization. Existing data also start to reveal how Ras proteins dimerize on the membrane. We propose a dimer model to describe Ras-mediated effector activation, which contrasts existing models of Ras signaling as a monomer or as a 5-8 membered multimer. We also discuss potential implications of this model in both basic and translational Ras biology.

AB - The K-, N-, and HRas small GTPases are key regulators of cell physiology and are frequently mutated in human cancers. Despite intensive research, previous efforts to target hyperactive Ras based on known mechanisms of Ras signaling have been met with little success. Several studies have provided compelling evidence for the existence and biological relevance of Ras dimers, establishing a new mechanism for regulating Ras activity in cells additionally to GTP-loading and membrane localization. Existing data also start to reveal how Ras proteins dimerize on the membrane. We propose a dimer model to describe Ras-mediated effector activation, which contrasts existing models of Ras signaling as a monomer or as a 5-8 membered multimer. We also discuss potential implications of this model in both basic and translational Ras biology.

KW - Cancer

KW - Membrane clustering

KW - Ras dimer

KW - Ras signaling

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84958964904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958964904&partnerID=8YFLogxK

M3 - Article

C2 - 26423697

AN - SCOPUS:84958964904

VL - 16

SP - 391

EP - 403

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 5

ER -